Platelet-Rich Plasma Shows Promise for Women's Gynecological Health Conditions
Comprehensive review reveals PRP therapy effectively treats vulvar conditions, sexual dysfunction, and urinary issues with minimal side effects.
Summary
This scoping review analyzed 43 studies examining platelet-rich plasma (PRP) therapy for non-fertility gynecological conditions. PRP showed particular promise for vulvar lichen sclerosus and sexual dysfunction, with patients experiencing symptom improvement and enhanced quality of life. The autologous treatment was generally well-tolerated with only minor side effects like injection-site pain. However, evidence for conditions like abnormal uterine bleeding and pelvic organ prolapse remained inconclusive, and significant variations in preparation protocols limited cross-study comparisons.
Detailed Summary
Platelet-rich plasma (PRP) therapy represents a promising minimally invasive treatment option for various gynecological conditions affecting women's quality of life. This comprehensive scoping review examined 43 studies to evaluate PRP's effectiveness beyond fertility applications, focusing on conditions like vulvar lichen sclerosus, sexual dysfunction, stress urinary incontinence, and interstitial cystitis.
The researchers conducted a systematic search across six major databases, screening 3,660 records according to PRISMA guidelines. They included randomized controlled trials, cohort studies, and case series examining PRP treatment for specific gynecological conditions in women of reproductive and postmenopausal age.
The results revealed particularly encouraging outcomes for vulvar lichen sclerosus and sexual dysfunction. Women with vulvar lichen sclerosus experienced significant improvements in symptoms and sexual function following PRP treatment. For sexual dysfunction, studies showed substantial improvements in Female Sexual Function Index scores, with some patients achieving normal sexual function. PRP also demonstrated benefits for vulvovaginal atrophy, with significant improvements in vaginal pH, fluid volume, and symptom scores.
Safety profiles were generally favorable across studies, with most adverse events being minor and transient, including injection-site pain and temporary discomfort. No serious complications were reported in the majority of studies, supporting PRP's safety profile as an autologous therapy.
However, the review identified significant limitations. Evidence for abnormal uterine bleeding and pelvic organ prolapse remained inconclusive, with some studies showing no additional benefits over standard treatments. The substantial heterogeneity in PRP preparation protocols, administration methods, and outcome measures across studies made direct comparisons challenging and limited the ability to establish standardized treatment protocols.
Key Findings
- PRP significantly improved symptoms in vulvar lichen sclerosus and sexual dysfunction patients
- Treatment was well-tolerated with only minor side effects like injection-site pain
- Evidence for abnormal uterine bleeding and pelvic organ prolapse remained inconclusive
- Substantial protocol variations limited cross-study comparisons and standardization
- 43 studies showed promise for PRP as minimally invasive gynecological therapy
Methodology
Scoping review following PRISMA-ScR guidelines searched six databases for studies on PRP in gynecological conditions. Included 43 studies comprising randomized controlled trials, cohort studies, and case series with independent screening and data extraction by multiple reviewers.
Study Limitations
Significant heterogeneity in PRP preparation methods and outcome measures limited cross-study comparisons. Some conditions showed inconclusive evidence, and most studies lacked long-term follow-up data. Standardization of protocols and larger randomized trials are needed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.